# Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB

> **NCT07672405** · PHASE2 · RECRUITING · sponsor: **Global Alliance for TB Drug Development** · enrollment: 100 (estimated)

## Conditions studied

- Tuberculosis, Pulmonary

## Interventions

- **DRUG:** sorfequiline
- **DRUG:** Pretomanid
- **DRUG:** Linezolid

## Key facts

- **NCT ID:** NCT07672405
- **Lead sponsor:** Global Alliance for TB Drug Development
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-09
- **Primary completion:** 2027-05-28
- **Final completion:** 2028-06-24
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07672405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07672405, "Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07672405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*